Recent acquisitions paid off in revenue and income growth for mobile imaging services provider Alliance Imaging in its first quarter (end-March).The Orange, CA, company reported 30% revenue growth, with sales of $19.1 million in the most recent quarter,
Recent acquisitions paid off in revenue and income growth for mobile imaging services provider Alliance Imaging in its first quarter (end-March).
The Orange, CA, company reported 30% revenue growth, with sales of $19.1 million in the most recent quarter, compared with $14.7 million in the same period the year before. Income before extraordinary items rose 25% to $1.7 million compared with the first quarter of 1996, while net income was $4.9 million.
CEO Richard Zehner credited procedural growth from new marketing programs and corporate acquisitions for the improvement. MRI utilization jumped by 33% to over 40,000 scans in the first quarter, he said. Alliance's new acquisitions-Royal Medical Health Services and Sun MRI Services-helped raise its quarterly revenue total by $2 million.
In other Alliance Imaging news, the company this month signed seven-year deals to provide MRI services to Washington Hospital in Fremont, CA, and CGH Medical Center in Sterling, IL.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.